Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Gains from Sales and Divestitures (2021 - 2023)

Historic Gains from Sales and Divestitures for SOPHiA GENETICS (SOPH) over the last 2 years, with Q4 2023 value amounting to $28000.0.

  • SOPHiA GENETICS's Gains from Sales and Divestitures changed N/A to $28000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $28000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that SOPHiA GENETICS reported Gains from Sales and Divestitures of $28000.0 as of Q4 2023.
  • Over the past 5 years, SOPHiA GENETICS's Gains from Sales and Divestitures peaked at $28000.0 during Q3 2023, and registered a low of $22000.0 during Q4 2021.